Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01241418

Publication Date:

January 4, 2024

Pages:

127

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period.
The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Transdermal Drug Delivery System. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Transdermal Drug Delivery System market.
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
Key Features:
The report on Transdermal Drug Delivery System market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Transdermal Drug Delivery System market. It may include historical data, market segmentation by Type (e.g., Fentanyl, Nitroglycerin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Transdermal Drug Delivery System market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Transdermal Drug Delivery System market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Transdermal Drug Delivery System industry. This include advancements in Transdermal Drug Delivery System technology, Transdermal Drug Delivery System new entrants, Transdermal Drug Delivery System new investment, and other innovations that are shaping the future of Transdermal Drug Delivery System.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Transdermal Drug Delivery System market. It includes factors influencing customer ' purchasing decisions, preferences for Transdermal Drug Delivery System product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Transdermal Drug Delivery System market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Transdermal Drug Delivery System market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Transdermal Drug Delivery System market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Transdermal Drug Delivery System industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Transdermal Drug Delivery System market.
Market Segmentation:
Transdermal Drug Delivery System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segmentation by application
OTC
Rx
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Drug Delivery System Market Size 2019-2030
2.1.2 Transdermal Drug Delivery System Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Transdermal Drug Delivery System Segment by Type
2.2.1 Fentanyl
2.2.2 Nitroglycerin
2.2.3 Estradiol
2.2.4 Nicotine
2.2.5 Other
2.3 Transdermal Drug Delivery System Market Size by Type
2.3.1 Transdermal Drug Delivery System Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Transdermal Drug Delivery System Market Size Market Share by Type (2019-2024)
2.4 Transdermal Drug Delivery System Segment by Application
2.4.1 OTC
2.4.2 Rx
2.5 Transdermal Drug Delivery System Market Size by Application
2.5.1 Transdermal Drug Delivery System Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Transdermal Drug Delivery System Market Size Market Share by Application (2019-2024)
3 Transdermal Drug Delivery System Market Size by Player
3.1 Transdermal Drug Delivery System Market Size Market Share by Players
3.1.1 Global Transdermal Drug Delivery System Revenue by Players (2019-2024)
3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2019-2024)
3.2 Global Transdermal Drug Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Transdermal Drug Delivery System by Regions
4.1 Transdermal Drug Delivery System Market Size by Regions (2019-2024)
4.2 Americas Transdermal Drug Delivery System Market Size Growth (2019-2024)
4.3 APAC Transdermal Drug Delivery System Market Size Growth (2019-2024)
4.4 Europe Transdermal Drug Delivery System Market Size Growth (2019-2024)
4.5 Middle East & Africa Transdermal Drug Delivery System Market Size Growth (2019-2024)
5 Americas
5.1 Americas Transdermal Drug Delivery System Market Size by Country (2019-2024)
5.2 Americas Transdermal Drug Delivery System Market Size by Type (2019-2024)
5.3 Americas Transdermal Drug Delivery System Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Drug Delivery System Market Size by Region (2019-2024)
6.2 APAC Transdermal Drug Delivery System Market Size by Type (2019-2024)
6.3 APAC Transdermal Drug Delivery System Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Transdermal Drug Delivery System by Country (2019-2024)
7.2 Europe Transdermal Drug Delivery System Market Size by Type (2019-2024)
7.3 Europe Transdermal Drug Delivery System Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Drug Delivery System by Region (2019-2024)
8.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2019-2024)
8.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Transdermal Drug Delivery System Market Forecast
10.1 Global Transdermal Drug Delivery System Forecast by Regions (2025-2030)
10.1.1 Global Transdermal Drug Delivery System Forecast by Regions (2025-2030)
10.1.2 Americas Transdermal Drug Delivery System Forecast
10.1.3 APAC Transdermal Drug Delivery System Forecast
10.1.4 Europe Transdermal Drug Delivery System Forecast
10.1.5 Middle East & Africa Transdermal Drug Delivery System Forecast
10.2 Americas Transdermal Drug Delivery System Forecast by Country (2025-2030)
10.2.1 United States Transdermal Drug Delivery System Market Forecast
10.2.2 Canada Transdermal Drug Delivery System Market Forecast
10.2.3 Mexico Transdermal Drug Delivery System Market Forecast
10.2.4 Brazil Transdermal Drug Delivery System Market Forecast
10.3 APAC Transdermal Drug Delivery System Forecast by Region (2025-2030)
10.3.1 China Transdermal Drug Delivery System Market Forecast
10.3.2 Japan Transdermal Drug Delivery System Market Forecast
10.3.3 Korea Transdermal Drug Delivery System Market Forecast
10.3.4 Southeast Asia Transdermal Drug Delivery System Market Forecast
10.3.5 India Transdermal Drug Delivery System Market Forecast
10.3.6 Australia Transdermal Drug Delivery System Market Forecast
10.4 Europe Transdermal Drug Delivery System Forecast by Country (2025-2030)
10.4.1 Germany Transdermal Drug Delivery System Market Forecast
10.4.2 France Transdermal Drug Delivery System Market Forecast
10.4.3 UK Transdermal Drug Delivery System Market Forecast
10.4.4 Italy Transdermal Drug Delivery System Market Forecast
10.4.5 Russia Transdermal Drug Delivery System Market Forecast
10.5 Middle East & Africa Transdermal Drug Delivery System Forecast by Region (2025-2030)
10.5.1 Egypt Transdermal Drug Delivery System Market Forecast
10.5.2 South Africa Transdermal Drug Delivery System Market Forecast
10.5.3 Israel Transdermal Drug Delivery System Market Forecast
10.5.4 Turkey Transdermal Drug Delivery System Market Forecast
10.5.5 GCC Countries Transdermal Drug Delivery System Market Forecast
10.6 Global Transdermal Drug Delivery System Forecast by Type (2025-2030)
10.7 Global Transdermal Drug Delivery System Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Hisamitsu
11.1.1 Hisamitsu Company Information
11.1.2 Hisamitsu Transdermal Drug Delivery System Product Offered
11.1.3 Hisamitsu Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Hisamitsu Main Business Overview
11.1.5 Hisamitsu Latest Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Transdermal Drug Delivery System Product Offered
11.2.3 Mylan Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Mylan Main Business Overview
11.2.5 Mylan Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Transdermal Drug Delivery System Product Offered
11.3.3 GSK Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Transdermal Drug Delivery System Product Offered
11.4.3 Novartis Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Information
11.5.2 Teve (Actavis) Transdermal Drug Delivery System Product Offered
11.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Teve (Actavis) Main Business Overview
11.5.5 Teve (Actavis) Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Transdermal Drug Delivery System Product Offered
11.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Lohmann
11.7.1 Lohmann Company Information
11.7.2 Lohmann Transdermal Drug Delivery System Product Offered
11.7.3 Lohmann Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Lohmann Main Business Overview
11.7.5 Lohmann Latest Developments
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Information
11.8.2 Teikoku Seiyaku Transdermal Drug Delivery System Product Offered
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Teikoku Seiyaku Main Business Overview
11.8.5 Teikoku Seiyaku Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Transdermal Drug Delivery System Product Offered
11.9.3 Bayer Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Lingrui
11.10.1 Lingrui Company Information
11.10.2 Lingrui Transdermal Drug Delivery System Product Offered
11.10.3 Lingrui Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Lingrui Main Business Overview
11.10.5 Lingrui Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Transdermal Drug Delivery System Product Offered
11.11.3 Sanofi Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 Qizheng
11.12.1 Qizheng Company Information
11.12.2 Qizheng Transdermal Drug Delivery System Product Offered
11.12.3 Qizheng Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Qizheng Main Business Overview
11.12.5 Qizheng Latest Developments
11.13 Endo
11.13.1 Endo Company Information
11.13.2 Endo Transdermal Drug Delivery System Product Offered
11.13.3 Endo Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Endo Main Business Overview
11.13.5 Endo Latest Developments
11.14 Huarun 999
11.14.1 Huarun 999 Company Information
11.14.2 Huarun 999 Transdermal Drug Delivery System Product Offered
11.14.3 Huarun 999 Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Huarun 999 Main Business Overview
11.14.5 Huarun 999 Latest Developments
11.15 Haw Par
11.15.1 Haw Par Company Information
11.15.2 Haw Par Transdermal Drug Delivery System Product Offered
11.15.3 Haw Par Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Haw Par Main Business Overview
11.15.5 Haw Par Latest Developments
11.16 Nichiban
11.16.1 Nichiban Company Information
11.16.2 Nichiban Transdermal Drug Delivery System Product Offered
11.16.3 Nichiban Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Nichiban Main Business Overview
11.16.5 Nichiban Latest Developments
11.17 Mentholatum
11.17.1 Mentholatum Company Information
11.17.2 Mentholatum Transdermal Drug Delivery System Product Offered
11.17.3 Mentholatum Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Mentholatum Main Business Overview
11.17.5 Mentholatum Latest Developments
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Information
11.18.2 Laboratoires Genevrier Transdermal Drug Delivery System Product Offered
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Laboratoires Genevrier Main Business Overview
11.18.5 Laboratoires Genevrier Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂